QPTFF (Quest PharmaTech) Dividend Payout Ratio: 0.00 (As of Jan. 2026)


What is Quest PharmaTech Dividend Payout Ratio?

Quest PharmaTech QPTFF Dividend Payout Ratio is 0.00 as of Jan. 2026. Among 134 Biotechnology companies, Quest PharmaTech ranks worse than 746267.91% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Quest PharmaTech's Dividend Payout Ratio for the months ended in Jan. 2026 was 0.00.

The historical rank and industry rank for Quest PharmaTech's Dividend Payout Ratio or its related term are showing as below:


QPTFF's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.445
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2026-07-02), the Dividend Yield % of Quest PharmaTech is 0.00%.

Quest PharmaTech's Dividends per Share for the months ended in Jan. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Quest PharmaTech (OTCPK:QPTFF) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Quest PharmaTech Dividend Payout Ratio Related Terms


Quest PharmaTech Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Quest PharmaTech's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech Dividend Payout Ratio Chart

Quest PharmaTech Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Quest PharmaTech Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

QPTFF vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Quest PharmaTech's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest PharmaTech Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Dividend Payout Ratio falls into.



Quest PharmaTech Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Quest PharmaTech's Dividend Payout Ratio for the fiscal year that ended in Jan. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Jan. 2026 )/ EPS without NRI (A: Jan. 2026 )
=0/ 0.01
=0.00

Quest PharmaTech's Dividend Payout Ratio for the quarter that ended in Jan. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jan. 2026 )/ EPS without NRI (Q: Jan. 2026 )
=0/ 0.003
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Quest PharmaTech (QPTFF) has a Dividend Payout Ratio of 0.00 as of Jan. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Quest PharmaTech and its competitors. According to the industry distribution chart, Quest PharmaTech ranks #999999 out of 134 companies in the Biotechnology industry.
Is Quest PharmaTech's Dividend Payout Ratio too high?
Quest PharmaTech's current Dividend Payout Ratio is 0.00. Based on the distribution chart, Quest PharmaTech ranks #999999 out of 134 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Quest PharmaTech's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Quest PharmaTech ranks #999999 out of 134 companies for Dividend Payout Ratio. This places Quest PharmaTech in the lower half of its industry. The industry median Dividend Payout Ratio is 0.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.45, based on 134 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Quest PharmaTech and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest PharmaTech's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest PharmaTech stock overvalued right now?
Quest PharmaTech (QPTFF) has a current Dividend Payout Ratio of 0.00. The current Dividend Payout Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Quest PharmaTech (QPTFF), the current Dividend Payout Ratio is 0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest PharmaTech Business Description

Other Exchanges QPT:Canada
Address 4342- 97 Street NW, Edmonton, AB, CAN, T6E 5R9
Quest PharmaTech Inc is developing targeted cancer therapy with its product (MAb AR9.6), under development for a novel target (truncated O-glycans on MUC16) discovered at the University of Nebraska Medical Center.